Vericel Corp Ord Net Income
| VCEL Stock | USD 37.09 1.16 3.03% |
As of the 25th of February, Vericel Corp has the Semi Deviation of 2.43, risk adjusted performance of 0.0098, and Coefficient Of Variation of 31001.06. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vericel Corp Ord, as well as the relationship between them. Please validate Vericel Corp Ord jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Vericel Corp is priced more or less accurately, providing market reflects its prevalent price of 37.09 per share. Given that Vericel Corp Ord has jensen alpha of 0.0165, we advise you to double-check Vericel Corp Ord's current market performance to make sure the company can sustain itself at a future point.
Vericel Corp Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.3158 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 11.9 M | 12.5 M | |
| Net Income From Continuing Ops | 11.9 M | 12.5 M | |
| Net Loss | -19.2 M | -20.2 M | |
| Net Income Per Share | 0.19 | 0.20 | |
| Net Income Per E B T | 0.89 | 0.82 |
Vericel | Net Income | Build AI portfolio with Vericel Stock |
Historical Net Income data for Vericel Corp serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Vericel Corp Ord represents a compelling investment opportunity.
Latest Vericel Corp's Net Income Growth Pattern
Below is the plot of the Net Income of Vericel Corp Ord over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Vericel Corp Ord financial statement analysis. It represents the amount of money remaining after all of Vericel Corp Ord operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Vericel Corp's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vericel Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 10.36 M | 10 Years Trend |
|
Net Income |
| Timeline |
Vericel Net Income Regression Statistics
| Arithmetic Mean | (9,134,446) | |
| Coefficient Of Variation | (135.29) | |
| Mean Deviation | 9,741,828 | |
| Median | (9,900,000) | |
| Standard Deviation | 12,357,871 | |
| Sample Variance | 152.7T | |
| Range | 42M | |
| R-Value | 0.79 | |
| Mean Square Error | 60T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 1,944,939 | |
| Total Sum of Squares | 2443.5T |
Vericel Net Income History
Other Fundumenentals of Vericel Corp Ord
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Vericel Corp Net Income component correlations
Vericel Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Vericel Corp is extremely important. It helps to project a fair market value of Vericel Stock properly, considering its historical fundamentals such as Net Income. Since Vericel Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vericel Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vericel Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.476 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth 0.166 | Return On Assets |
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.
Vericel Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vericel Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vericel Corp.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in Vericel Corp on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Vericel Corp Ord or generate 0.0% return on investment in Vericel Corp over 90 days. Vericel Corp is related to or competes with Uniqure NV, Structure Therapeutics, Edgewise Therapeutics, Viridian Therapeutics, Aurinia Pharmaceuticals, Nuvation Bio, and MannKind Corp. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, an... More
Vericel Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vericel Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vericel Corp Ord upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.5 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 14.74 | |||
| Value At Risk | (4.07) | |||
| Potential Upside | 4.57 |
Vericel Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vericel Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vericel Corp's standard deviation. In reality, there are many statistical measures that can use Vericel Corp historical prices to predict the future Vericel Corp's volatility.| Risk Adjusted Performance | 0.0098 | |||
| Jensen Alpha | 0.0165 | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.0045 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vericel Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vericel Corp February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0098 | |||
| Market Risk Adjusted Performance | 0.0145 | |||
| Mean Deviation | 2.19 | |||
| Semi Deviation | 2.43 | |||
| Downside Deviation | 2.5 | |||
| Coefficient Of Variation | 31001.06 | |||
| Standard Deviation | 2.86 | |||
| Variance | 8.17 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | 0.0165 | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.0045 | |||
| Maximum Drawdown | 14.74 | |||
| Value At Risk | (4.07) | |||
| Potential Upside | 4.57 | |||
| Downside Variance | 6.27 | |||
| Semi Variance | 5.92 | |||
| Expected Short fall | (2.59) | |||
| Skewness | 0.6443 | |||
| Kurtosis | 0.7905 |
Vericel Corp Ord Backtested Returns
Vericel Corp Ord owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0401, which indicates the firm had a -0.0401 % return per unit of risk over the last 3 months. Vericel Corp Ord exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vericel Corp's Risk Adjusted Performance of 0.0098, coefficient of variation of 31001.06, and Semi Deviation of 2.43 to confirm the risk estimate we provide. The entity has a beta of -0.17, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Vericel Corp are expected to decrease at a much lower rate. During the bear market, Vericel Corp is likely to outperform the market. At this point, Vericel Corp Ord has a negative expected return of -0.1%. Please make sure to validate Vericel Corp's skewness, and the relationship between the potential upside and rate of daily change , to decide if Vericel Corp Ord performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.43 |
Average predictability
Vericel Corp Ord has average predictability. Overlapping area represents the amount of predictability between Vericel Corp time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vericel Corp Ord price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Vericel Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 1.36 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Vericel Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Vericel Corp Ord reported net income of 10.36 M. This is 96.96% lower than that of the Biotechnology sector and 85.21% lower than that of the Health Care industry. The net income for all United States stocks is 98.19% higher than that of the company.
Vericel Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vericel Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics of similar companies.Vericel Corp is currently under evaluation in net income category among its peers.
Vericel Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vericel Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vericel Corp's managers, analysts, and investors.Environmental | Governance | Social |
Vericel Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Vericel Corp that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Vericel Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vericel Corp's value.| Shares | William Blair Investment Management, Llc | 2025-06-30 | 1.2 M | Federated Hermes Inc | 2025-06-30 | 1.1 M | Bnp Paribas Investment Partners Sa | 2025-06-30 | 1.1 M | Royal Bank Of Canada | 2025-06-30 | 1.1 M | Loomis, Sayles & Company Lp | 2025-06-30 | 1 M | Champlain Investment Partners, Llc | 2025-06-30 | 997.3 K | New York State Common Retirement Fund | 2025-06-30 | 890.5 K | Allspring Global Investments Holdings, Llc | 2025-06-30 | 859.5 K | Capital Research Global Investors | 2025-06-30 | 853.7 K | Blackrock Inc | 2025-06-30 | 7.6 M | Vanguard Group Inc | 2025-06-30 | 3.6 M |
Vericel Fundamentals
| Return On Equity | 0.0452 | ||||
| Return On Asset | 0.0105 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.57 B | ||||
| Shares Outstanding | 50.57 M | ||||
| Shares Owned By Insiders | 2.33 % | ||||
| Shares Owned By Institutions | 97.67 % | ||||
| Number Of Shares Shorted | 4.6 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 5.18 X | ||||
| Price To Sales | 7.48 X | ||||
| Revenue | 237.22 M | ||||
| Gross Profit | 190.97 M | ||||
| EBITDA | 16.63 M | ||||
| Net Income | 10.36 M | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 98.85 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 6.37 X | ||||
| Cash Flow From Operations | 58.16 M | ||||
| Short Ratio | 8.78 X | ||||
| Earnings Per Share | 0.26 X | ||||
| Target Price | 55.0 | ||||
| Number Of Employees | 357 | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 1.93 B | ||||
| Total Asset | 432.72 M | ||||
| Retained Earnings | (392.81 M) | ||||
| Working Capital | 162.49 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
| Net Asset | 432.72 M |
About Vericel Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.476 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth 0.166 | Return On Assets |
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.